Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010

被引:309
作者
Nelson, Christina A. [1 ]
Saha, Shubhayu [2 ]
Kugeler, Kiersten J. [1 ]
Delorey, Mark J. [1 ]
Shankar, Manjunath B. [2 ]
Hinckley, Alison F. [1 ]
Mead, Paul S. [1 ]
机构
[1] Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
SURVEILLANCE; ACCURACY;
D O I
10.3201/eid2109.150417
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
National surveillance provides important information about Lyme disease (LD) but is subject to underreporting and variations in practice. Information is limited about the national epidemiology of LD from other sources. Retrospective analysis of a nationwide health insurance claims database identified patients from 2005-2010 with clinician-diagnosed LD using International Classification of Diseases, Ninth Revision, Clinical Modification, codes and antimicrobial drug prescriptions. Of 103,647,966 person-years, 985 inpatient admissions and 44,445 outpatient LD diagnoses were identified. Epidemiologic patterns were similar to US surveillance data overall. Outpatient incidence was highest among boys 5-9 years of age and persons of both sexes 60-64 years of age. On the basis of extrapolation to the US population and application of correction factors for coding, we estimate that annual incidence is 106.6 cases/100,000 persons and that approximate to 329,000 (95% credible interval 296,000-376,000) LD cases occur annually. LD is a major US public health problem that causes substantial use of health care resources.
引用
收藏
页码:1625 / 1631
页数:7
相关论文
共 28 条
[1]  
Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1
[2]  
[Anonymous], 2014, MMWR-MORBID MORTAL W, V63, P702
[3]  
Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1
[4]   Effect of gender on clinical and epidemiologic features of Lyme borreliosis [J].
Bennet, Louise ;
Stjernberg, Louise ;
Berglund, Johan .
VECTOR-BORNE AND ZOONOTIC DISEASES, 2007, 7 (01) :34-41
[5]  
Campbell GL, 1998, AM J EPIDEMIOL, V148, P1018, DOI 10.1093/oxfordjournals.aje.a009568
[6]   Enhancing Lyme Disease Surveillance by Using Administrative Claims Data, Tennessee, USA [J].
Clayton, Joshua L. ;
Jones, Stephen G. ;
Dunn, John R. ;
Schaffner, William ;
Jones, Timothy F. .
EMERGING INFECTIOUS DISEASES, 2015, 21 (09) :1632-1634
[7]   The public health impact of Lyme disease in Maryland [J].
Coyle, BS ;
Strickland, GT ;
Liang, YY ;
Pena, C ;
McCarter, R ;
Israel, E .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) :1260-1262
[8]  
Halperin John J, 2014, Handb Clin Neurol, V121, P1473, DOI 10.1016/B978-0-7020-4088-7.00099-7
[9]   Lyme Disease Testing by Large Commercial Laboratories in the United States [J].
Hinckley, Alison F. ;
Connally, Neeta P. ;
Meek, James I. ;
Johnson, Barbara J. ;
Kemperman, Melissa M. ;
Feldman, Katherine A. ;
White, Jennifer L. ;
Mead, Paul S. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (05) :676-681
[10]  
Janes G, 2000, PRINCIPLES AND PRACT